Subburaman Mohan

22.5k total citations · 1 hit paper
366 papers, 18.0k citations indexed

About

Subburaman Mohan is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Genetics. According to data from OpenAlex, Subburaman Mohan has authored 366 papers receiving a total of 18.0k indexed citations (citations by other indexed papers that have themselves been cited), including 220 papers in Molecular Biology, 186 papers in Endocrinology, Diabetes and Metabolism and 82 papers in Genetics. Recurrent topics in Subburaman Mohan's work include Growth Hormone and Insulin-like Growth Factors (173 papers), Bone Metabolism and Diseases (86 papers) and Bone health and treatments (45 papers). Subburaman Mohan is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (173 papers), Bone Metabolism and Diseases (86 papers) and Bone health and treatments (45 papers). Subburaman Mohan collaborates with scholars based in United States, Sweden and Germany. Subburaman Mohan's co-authors include David J. Baylink, David J. Baylink, Thomas A. Linkhart, Jon E. Wergedal, Sujatha Rajaram, D J Baylink, Donna D. Strong, Richard D. Finkelman, Weirong Xing and Claes Ohlsson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Subburaman Mohan

362 papers receiving 17.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Insulin-Like Growth Factor-Binding Proteins in Serum and Other Biological Fluids: Regulation and Functions*

1997 894 citations David J. Baylink, Subburaman Mohan et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Subburaman Mohan United States	72	8.7k	7.8k	3.6k	2.6k	2.5k	366	18.0k
David J. Baylink United States	66	7.5k 0.9×	4.0k 0.5×	2.6k 0.7×	3.6k 1.4×	2.6k 1.0×	239	14.8k
Andrew R. Hoffman United States	76	7.5k 0.9×	6.0k 0.8×	3.1k 0.9×	1.4k 0.5×	1.2k 0.5×	343	18.3k
Shoshana Yakar United States	61	6.8k 0.8×	6.9k 0.9×	2.1k 0.6×	866 0.3×	2.0k 0.8×	172	13.7k
Patricia Ducy United States	42	11.3k 1.3×	2.7k 0.3×	2.5k 0.7×	4.4k 1.7×	4.7k 1.8×	68	21.4k
Thomas L. Clemens United States	68	6.8k 0.8×	2.0k 0.3×	2.2k 0.6×	2.8k 1.1×	3.2k 1.3×	157	15.3k
Ernesto Canalis United States	87	14.5k 1.7×	5.5k 0.7×	3.4k 1.0×	5.2k 2.0×	6.8k 2.7×	332	25.3k
David J. Baylink United States	65	5.1k 0.6×	3.7k 0.5×	1.9k 0.5×	3.5k 1.3×	2.6k 1.0×	263	12.6k
Mone Zaidi United States	63	7.2k 0.8×	2.5k 0.3×	1.4k 0.4×	2.5k 1.0×	3.1k 1.2×	308	14.0k
Wesley G. Beamer United States	53	5.1k 0.6×	3.0k 0.4×	2.6k 0.7×	2.1k 0.8×	1.4k 0.6×	176	10.3k
David Goltzman Canada	82	8.8k 1.0×	1.8k 0.2×	2.8k 0.8×	4.7k 1.8×	6.9k 2.7×	410	21.0k

Countries citing papers authored by Subburaman Mohan

Since Specialization

Citations

This map shows the geographic impact of Subburaman Mohan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Subburaman Mohan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Subburaman Mohan more than expected).

Fields of papers citing papers by Subburaman Mohan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Subburaman Mohan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Subburaman Mohan. The network helps show where Subburaman Mohan may publish in the future.

Co-authorship network of co-authors of Subburaman Mohan

This figure shows the co-authorship network connecting the top 25 collaborators of Subburaman Mohan. A scholar is included among the top collaborators of Subburaman Mohan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Subburaman Mohan. Subburaman Mohan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gomez, Gustavo A., et al.. (2024). Sex-Specific Effects of THRβ Signaling on Metabolic Responses to High Fat Diet in Mice. Endocrinology. 165(8). 3 indexed citations

Zeng, Canjun, Yi‐An Chen, Jean Vacher, et al.. (2023). Leucine Repeat Rich Kinase 1 Controls Osteoclast Activity by Managing Lysosomal Trafficking and Secretion. Biology. 12(4). 511–511. 3 indexed citations

Xing, Weirong, et al.. (2022). Lack of Skeletal Effects in Mice with Targeted Disruptionof Prolyl Hydroxylase Domain 1 (Phd1) Gene Expressed in Chondrocytes. Life. 13(1). 106–106. 4 indexed citations

Fujiwara, Toshifumi, Jian Zhou, Nükhet Aykin‐Burns, et al.. (2022). Transferrin receptor 1-mediated iron uptake regulates bone mass in mice via osteoclast mitochondria and cytoskeleton. eLife. 11. 46 indexed citations

Mohan, Subburaman, et al.. (2022). Role of prolyl hydroxylase domain proteins in bone metabolism. SHILAP Revista de lepidopterología. 8(1). 1–10. 7 indexed citations

Haro, Endika, et al.. (2017). Lmx1b-targeted cis -regulatory modules involved in limb dorsalization. Development. 144(11). 2009–2020. 15 indexed citations

Yu, Hongrun, Jon E. Wergedal, Yongliang Zhao, & Subburaman Mohan. (2012). Targeted Disruption of TGFBI in Mice Reveals Its Role in Regulating Bone Mass and Bone Size through Periosteal Bone Formation. Calcified Tissue International. 91(1). 81–87. 27 indexed citations

Sjögren, Klara, Marie K. Lagerquist, Sofia Movérare‐Skrtic, et al.. (2009). Elevated Aromatase Expression in Osteoblasts Leads to Increased Bone Mass Without Systemic Adverse Effects. Journal of Bone and Mineral Research. 24(7). 1263–1270. 42 indexed citations

Ehrnborg, Christer, Claes Ohlsson, Subburaman Mohan, Bengt‐Åke Bengtsson, & Thord Rosén. (2007). Increased serum concentration of IGFBP-4 and IGFBP-5 in healthy adults during one month’s treatment with supraphysiological doses of growth hormone. Growth Hormone & IGF Research. 17(3). 234–241. 10 indexed citations

10.

Rooman, Raoul, et al.. (2005). Ethinylestradiol and testosterone have divergent effects on circulating IGF system components in adolescents with constitutional tall stature. European Journal of Endocrinology. 152(4). 597–604. 27 indexed citations

11.

Walenkamp, M.J.E., Marcel Karperien, Alberto M. Pereira, et al.. (2005). Homozygous and Heterozygous Expression of a Novel Insulin-Like Growth Factor-I Mutation. The Journal of Clinical Endocrinology & Metabolism. 90(5). 2855–2864. 239 indexed citations

12.

Qin, Xuezhong, Christopher Sexton, Dong Won Byun, et al.. (2002). Differential regulation of pregnancy associated plasma protein (PAPP)-A during pregnancy in human and mouse. Growth Hormone & IGF Research. 12(5). 359–366. 22 indexed citations

13.

Kasukawa, Yuji, et al.. (2002). Effect of insulin-like growth factor-1 (IGF-1) plus alendronate on bone density during puberty in IGF-1-deficient MIDI mice. Bone. 30(6). 909–916. 31 indexed citations

14.

Gu, Weikuan, Xiaojing Li, Donna D. Strong, et al.. (2002). Construction of a BAC Contig for a 3 cM Biologically Significant Region of Mouse Chromosome 1. Genetica. 114(1). 1–9. 9 indexed citations

15.

Mohan, Subburaman, et al.. (2001). Localization of the IGF binding domain and evaluation of the role of cysteine residues in IGF binding in IGF binding protein-4. Journal of Endocrinology. 169(1). 135–143. 11 indexed citations

16.

Miyakoshi, Naohisa, Charmaine Richman, Yuji Kasukawa, et al.. (2001). Evidence that IGF-binding protein-5 functions as a growth factor. Journal of Clinical Investigation. 107(1). 73–81. 175 indexed citations

17.

Lindberg, Mattias, et al.. (2001). Estrogen receptor specificity in the regulation of the skeleton in female mice. Journal of Endocrinology. 171(2). 229–236. 174 indexed citations

18.

Kaplan, Paula, Subburaman Mohan, Peter Cohen, Barbara A. Foster, & Norman M. Greenberg. (1999). The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model.. PubMed. 59(9). 2203–9. 177 indexed citations

19.

Jehle, P. M., et al.. (1998). Serum levels of insulin-like growth factor system components and relationship to bone metabolism in Type 1 and Type 2 diabetes mellitus patients. Journal of Endocrinology. 159(2). 297–306. 158 indexed citations

20.

Mohan, Subburaman, et al.. (1992). Studies on regulation of insulin-like growth factor binding protein (IGFBP)-3 and IGFBP-4 production in human bone cells. European Journal of Endocrinology. 127(6). 555–564. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact